Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis

Annals of the Rheumatic Diseases

Volumn 70, Issue 7, 2011, Pages 1223-1230

  Eckstein, F ^a,b   Hellio Le Graverand, M P ^c   Charles, H C ^d   Hunter, D J ^e   Kraus, V B ^d   Sunyer, T ^c   Nemirovskyi, O ^c   Wyman, B T ^c   Buck, R ^f  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b Chondrometrics GmbH   (Germany)

^c PFIZER INC   (United States)

^d DUKE UNIVERSITY   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f StatAnswers Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; GADOLINIUM; PROTEOGLYCAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARTILAGE LOSS; CHONDROPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FEMUR; FOLLOW UP; HUMAN; KNEE MENISCUS; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PRIORITY JOURNAL; SCORING SYSTEM; TIBIA;

AGED; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROGNOSIS;

EID: 79957640007     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.141382     Document Type: Article

References (63)

1. Lohmander LS, Felson D. Can we identify a 'high risk' patient profile to determine who will experience rapid progression of osteoarthritis? Osteoarthr Cartil 2004;12(Suppl A):S49-52.
2. Cheung PP, Gossec L, Dougados M. What are the best markers for disease progression in osteoarthritis (OA)? Best Pract Res Clin Rheumatol 2010;24:81-92.
3. Belo JN, Berger MY, Reijman M, et al. Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studies. Arthritis Rheum 2007;57:13-26.
4. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum 2004;50:476-87. (Pubitemid 38198832)
5. Cicuttini FM, Jones G, Forbes A, et al. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis 2004;63:1124-7.
6. Cicuttini F, Wluka A, Hankin J, et al. Longitudinal study of the relationship between knee angle and tibiofemoral cartilage volume in subjects with knee osteoarthritis. Rheumatology (Oxford) 2004;43:321-4. (Pubitemid 38313181)
7. Sharma L, Eckstein F, Song J, et al. Relationship of meniscal damage, meniscal extrusion, malalignment, and joint laxity to subsequent cartilage loss in osteoarthritic knees. Arthritis Rheum 2008;58:1716-26. (Pubitemid 351847525)
8. Eckstein F, Wirth W, Hudelmaier M, et al. Patterns of femorotibial cartilage loss in knees with neutral, varus, and valgus alignment. Arthritis Rheum 2008;59:1563-70.
9. Eckstein F, Maschek S, Wirth W, et al. One year change of knee cartilage morphology in the first release of participants from the Osteoarthritis Initiative progression subcohort: association with sex, body mass index, symptoms and radiographic osteoarthritis status. Ann Rheum Dis 2009;68:674-9.
10. Eckstein F, Benichou O, Wirth W, et al. Direct comparison of cartilage loss in painful contra-lateral knees with and without joint space narrowing - data from the Osteoarthritis Initiative (OAI). Arthritis Care Res 2009;9:1218-25.
11. Le Graverand MP, Buck RJ, Wyman BT, et al. Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon-Schuss radiography. Ann Rheum Dis 2010;69:155-62.
12. Kraus VB, Feng S, Wang S, et al. Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression. Arthritis Rheum 2009;60:3711-22.
13. Berthiaume MJ, Raynauld JP, Martel-Pelletier J, et al. Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis 2005;64:556-63. (Pubitemid 40469084)
14. Hunter DJ, Zhang YQ, Niu JB, et al. The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum 2006;54:795-801.
15. Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003;139:330-6.
16. Hunter DJ, Zhang Y, Niu J, et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006;54:1529-35.
17. Tanishi N, Yamagiwa H, Hayami T, et al. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey. J Bone Miner Metab 2009;27:605-12.
18. Ling SM, Patel DD, Garnero P, et al. Serum protein signatures detect early radiographic osteoarthritis. Osteoarthr Cartil 2009;17:43-8.
19. Garnero P, Aronstein WS, Cohen SB, et al. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. Osteoarthr Cartil 2008;16:660-6. (Pubitemid 351760798)
20. Cahue S, Sharma L, Dunlop D, et al. T he ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthr Cartil 2007;15:819-23. (Pubitemid 46888162)
21. Hellio Le Graverand MP, Brandt KD, Mazzuca SA, et al. Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis. Osteoarthritis Cartilage 2006;14:1189-95. (Pubitemid 44490308)
22. Mazzuca SA, Brandt KD, Eyre DR, et al. Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis. Ann Rheum Dis 2006;65:1055-9. (Pubitemid 44133269)
23. Deberg MA, Labasse AH, Collette J, et al. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. Osteoarthr Cartil 2005;13:1059-65. (Pubitemid 41672503)
24. Takahashi M, Naito K, Abe M, et al. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 2004;6:R208-12.
25. Garnero P, Ayral X, Rousseau JC, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002;46:2613-24. (Pubitemid 36118924)
26. Bruyere O, Collette J, Kothari M, et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 2006;65:1050-4. (Pubitemid 44133268)
27. Dam EB, Byrjalsen I, Karsdal MA, et al. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthr Cartil 2009;17:384-9.
28. Hunter DJ, Lavalley M, Li J, et al. Urinary pentosidine does not predict cartilage loss among subjects with symptomatic knee OA: the BOKS Study. Osteoarthr Cartil 2007;15:93-7. (Pubitemid 46117913)
29. Berry PA, Maciewicz RA, Cicuttini FM, et al. Markers of bone formation and resorption identify subgroups of patients with clinical knee osteoarthritis who have reduced rates of cartilage loss. J Rheumatol 2010;37:1252-9.
30. Pelletier JP, Raynauld JP, Caron J, et al. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann Rheum Dis 2010;69:2095-101.
31. Mosher TJ, Dardzinski BJ. Cartilage MRI T2 relaxation time mapping: overview and applications. Semin Musculoskelet Radiol 2004;8:355-68. (Pubitemid 40083118)
32. Guermazi A, Burstein D, Conaghan P, et al. Imaging in osteoarthritis. Rheum Dis Clin North Am 2008;34:645-87.
33. Gray ML, Burstein D, Kim YJ, et al. 2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartilage glycosaminoglycan: basic principles, imaging technique, and clinical applications. J Orthop Res 2008;3:281-91.
34. Burstein D, Gray M, Mosher T, et al. Measures of molecular composition and structure in osteoarthritis. Radiol Clin North Am 2009;47:675-86.
35. Owman H, Tiderius CJ, Neuman P, et al. Association between findings on delayed gadolinium-enhanced magnetic resonance imaging of cartilage and future knee osteoarthritis. Arthritis Rheum 2008;58:1727-30. (Pubitemid 351847526)
36. Buck RJ, Wyman BT, Le Graverand MP, et al. O steoarthritis may not be a one-way-road of cartilage loss - comparison of spatial patterns of cartilage change between osteoarthritic and healthy knees. Osteoarthr Cartil 2010;18:329-35.
37. Hellio Le Graverand MP, Buck RJ, Wyman BT, et al. Subregional femorotibial cartilage morphology in women - comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis. Osteoarthritis Cartilage 2009;17:1177-85.
38. Eckstein F, Buck RJ, Burstein D, et al. Precision of 3.0 Tesla quantitative magnetic resonance imaging of cartilage morphology in a multicentre clinical trial. Ann Rheum Dis 2008;67:1683-8.
39. Hudelmaier M, Wirth W, Wehr B, et al. Femorotibial cartilage morphology: reproducibility of different metrics and femoral regions, and sensitivity to change in disease. Cells Tissues Organs (Print) 2010;192:340-50.
40. Le Graverand MP, Vignon EP, Brandt KD, et al. Head-to-head comparison of the Lyon Schuss and fixed flexion radiographic techniques. Long-term reproducibility in normal knees and sensitivity to change in osteoarthritic knees. Ann Rheum Dis 2008;67:1562-6.
41. Vignon E, Piperno M, Le Graverand MP, et al. Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon schuss views. Arthritis Rheum 2003;48:378-84. (Pubitemid 36278005)
42. Wirth W, Eckstein F. A technique for regional analysis of femorotibial cartilage thickness based on quantitative magnetic resonance imaging. IEEE Trans Med Imaging 2008;27:737-44. (Pubitemid 351760846)
43. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40. (Pubitemid 19037656)
44. Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil 2007;15(Suppl A):A1-56.
45. Altman RD, Hochberg M, Murphy WA, Jr, et al. Atlas of individual radiographic features in osteoarthritis. Osteoarthr Cartil 1995;3(Suppl A):3-70.
46. Kraus VB, Vail TP, Worrell T, et al. A comparative assessment of alignment angle of the knee by radiographic and physical examination methods. Arthritis Rheum 2005;52:1730-5. (Pubitemid 40852881)
47. Nemirovskiy OV, Sunyer T, Aggarwal P, et al. Discovery and development of the N-terminal procollagen type II (NPII) biomarker: a tool for measuring collagen type II synthesis. Osteoarthr Cartil 2008;16:1494-500.
48. Nemirovskiy OV, Dufield DR, Sunyer T, et al. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. Anal Biochem 2007;361:93-101. (Pubitemid 46026997)
49. Li WW, Nemirovskiy O, Fountain S, et al. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: a biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Anal Biochem 2007;369:41-53. (Pubitemid 47313372)
50. Settle S, Vickery L, Nemirovskiy O, et al. Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: confirmation by multivariate analysis that modulation of type II collagen and aggrecan degradation peptides parallels pathologic changes. Arthritis Rheum 2010;62:3006-15.
51. Dufield DR, Nemirovskiy OV, Jennings MG, et al. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: use as a biomarker for aggrecanase activity and cartilage degradation. Anal Biochem 2010;406:113-23.
52. Nemirovskiy OV, Radabaugh MR, Aggarwal P, et al. Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: pharmacological dissection of iNOS' role in disease. Nitric Oxide 2009;20:150-6.
53. Hunter DJ, Buck R, Vignon E, et al. Relation of regional articular cartilage morphometry and meniscal position by MRI to joint space width in knee radiographs. Osteoarthr Cartil 2009;17:1170-6.
54. McKenzie CA, Williams A, Prasad PV, et al. Three-dimensional delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at 1.5T and 3.0T. J Magn Reson Imaging 2006;24:928-33. (Pubitemid 44547008)
55. Burgkart R, Glaser C, Hyhlik-Dürr A, et al. Magnetic resonance imaging-based assessment of cartilage loss in severe osteoarthritis: accuracy, precision, and diagnostic value. Arthritis Rheum 2001;44:2072-7 (Pubitemid 33644050)
56. Graichen H, von Eisenhart-Rothe R, Vogl T, et al. Quantitative assessment of cartilage status in osteoarthritis by quantitative magnetic resonance imaging: technical validation for use in analysis of cartilage volume and further morphologic parameters. Arthritis Rheum 2004;50:811-16. (Pubitemid 38326181)
57. Eckstein F, Hellio-Le Graverand MP, Charles C, et al. Which baseline factors predict cartilage thinning and thickening in OA knees - results from the A9001140 study. Osteoarthritis Cartilage 2009;17(Suppl 1):S215(abstract).
58. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990;9:811-18. (Pubitemid 20343989)
59. Le Graverand MP, Brandt K, Mazzuca SA, et al. Progressive increase in body mass index is not associated with a progressive increase in joint space narrowing in obese women with osteoarthritis of the knee. Ann Rheum Dis 2009;68:1734-8.
60. Eckstein F, Wirth W, Hudelmaier MI, et al. Relationship of compartment-specific structural knee status at baseline with change in cartilage morphology: a prospective observational study using data from the osteoarthritis initiative. Arthritis Res Ther 2009;11:R90.
61. Bettica P, Cline G, Hart DJ, et al. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 2002;46:3178-84. (Pubitemid 35453526)
62. Dardzinski BJ, Mosher TJ, Li S, et al. Spatial variation of T2 in human articular cartilage. Radiology 1997;205:546-50. (Pubitemid 27467340)
63. Juras V, Bittsansky M, Majdisova Z, et al. In vitro determination of biomechanical properties of human articular cartilage in osteoarthritis using multi-parametric MRI. J Magn Reson 2009;197:40-7.